Plain-English translation of NCT07375433 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is investigating how a specific heart condition called preserved ejection fraction heart failure develops in people with chronic obstructive pulmonary disease (COPD). Researchers want to understand how often this heart problem occurs alongside COPD, what symptoms patients experience, and how it affects their overall health and survival over time.
Many people with COPD also develop heart problems that often go undiagnosed. This study exists to find out how common this heart-lung connection is and whether catching these heart problems early could improve outcomes for COPD patients.
You likely qualify if…
You likely don't qualify if…
You would undergo standard hospital heart and lung tests, including blood work, heart ultrasound, breathing tests, and a walking test to measure your fitness. Researchers will also review your medical records and track your health status over 12 months, noting any hospitalizations and their causes. The study does not involve taking a new medication — it focuses on understanding your current condition through standard medical tests.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Russia
Sponsor
National Medical Research Center for Therapy and Preventive Medicine
Collaborators
Kazan State Medical University
Enrollment target
~200 participants
Started
January 2026
Primary completion
December 2026
Age range
50 Years – 70 Years
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yury S Timofeev, PhD
National Medical Research Center for Therapy and Preventive Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.